Export share
48%
+23pp YoY
Export share increased from 25% in Q2 FY26 to 48% in Q3 FY26, driven by CCT acquisition.
FINEOTEXCHEMICAL
Manufacturing
10 Feb 2026
Fineotex Chemical Ltd — Q3 FY26
Fineotex Chemical delivered a strong Q3 FY26 with revenue surging 46% YoY to ₹190 crore, driven by the acquisition of Crude Chem Technology (CCT) and improving demand in textiles and oil & gas.
✓ Verified against BSE filing
2-Min Summary
✦ AI-Generated from Full Transcript
Fineotex Chemical delivered a strong Q3 FY26 with revenue surging 46% YoY to ₹190 crore, driven by the acquisition of Crude Chem Technology (CCT) and improving demand in textiles and oil & gas. Export share jumped to 48% from 25% last quarter, reflecting successful international expansion. The company maintained a debt-free balance sheet with ₹340 crore cash and received ₹35.68 crore from warrant conversions. Management guided for ₹1,000 crore+ revenue in FY27, with oil & gas expected to contribute 45-50% of sales. Capacity utilization stands at 64%, with 39% volume growth YoY. Risks include integration challenges at CCT and potential margin pressure from textile pricing rollbacks.
Key Numbers
Volume growth (YoY)
39%
+39% YoY
Overall volume growth including CCT; excludes standalone volume breakdown.
Capacity utilization
64%
flat
Overall capacity utilization across all plants; new Amber plant commissioned recently.
CCT annual revenue
$65M
flat
Crude Chem Technology's annual revenue run-rate of ~$65-66 million as per last records.
Management Guidance
FY27 revenue target of ₹1,000 crore+
Management expects consolidated revenue to exceed ₹1,000 crore in the next financial year, driven by CCT full-year contribution and textile recovery.
Management guidance revenueOil & gas to contribute 45-50% of revenue
Oil & gas segment (including CCT) is expected to account for 45-50% of total revenue going forward.
Management guidance growthCCT margins to improve to double digits
CCT's EBITDA margins, historically around 7-8%, are expected to improve to double digits due to capital infusion and better procurement.
Management guidance marginsCapex of ₹70-80 crore over 1.5-2 years
Capital expenditure for CCT expansion and other projects is expected to be around ₹70-80 crore (less than $10 million) over the next 1.5-2 years.
Management guidance capexKey Risks
CCT integration and margin improvement timeline
CCT was consolidated for only 15 days in Q3; achieving double-digit margins may take longer than expected due to integration complexities.
medium · analyst_questionTextile margin pressure from discount rollback
Management provided discounts to textile customers during the tariff uncertainty and plans to roll them back from March 2026, which could impact customer retention.
medium · management_commentaryDomestic revenue stagnation
Domestic revenue remained flat YoY at ~₹95.6 crore, indicating limited organic growth in the home market despite new capacity.
medium · data_observationDependence on US trade policy for textile recovery
Textile recovery hinges on favorable US tariff resolution; any reversal or delay could impact expected order book improvement.
high · management_commentaryNotable Quotes
This acquisition is fully aligned with our communicated growth plan and a long-term strategy of expanding into technology-driven specialty segments.
Our export shares has increased significantly to 48% in quarter 3 financial year 26 from 25% last quarter demonstrating our growing international presence and traction.
I'm very sure in the next financial year we are going to be 1,000 cr plus company in terms of businesses so that's given from your own derivations.
Frequently Asked Questions
What was Fineotex Chemical's revenue in Q3 FY26?
Fineotex Chemical reported revenue of ₹184 Cr in Q3 FY26, representing a +46% change compared to the same quarter last year.
What guidance did Fineotex Chemical management give for FY27?
FY27 revenue target of ₹1,000 crore+: Management expects consolidated revenue to exceed ₹1,000 crore in the next financial year, driven by CCT full-year contribution and textile recovery. Oil & gas to contribute 45-50% of revenue: Oil & gas segment (including CCT) is expected to account for 45-50% of total revenue going forward. CCT margins to improve to double digits: CCT's EBITDA margins, historically around 7-8%, are expected to improve to double digits due to capital infusion and better procurement. Capex of ₹70-80 crore over 1.5-2 years: Capital expenditure for CCT expansion and other projects is expected to be around ₹70-80 crore (less than $10 million) over the next 1.5-2 years.
What are the key risks for Fineotex Chemical in FY27?
Key risks include CCT integration and margin improvement timeline — CCT was consolidated for only 15 days in Q3; achieving double-digit margins may take longer than expected due to integration complexities.; Textile margin pressure from discount rollback — Management provided discounts to textile customers during the tariff uncertainty and plans to roll them back from March 2026, which could impact customer retention.; Domestic revenue stagnation — Domestic revenue remained flat YoY at ~₹95.6 crore, indicating limited organic growth in the home market despite new capacity.; Dependence on US trade policy for textile recovery — Textile recovery hinges on favorable US tariff resolution; any reversal or delay could impact expected order book improvement..
Did Fineotex Chemical meet its previous quarter's guidance?
Scorecard data is being built as historical quarters are processed.
Where can I read the full Fineotex Chemical Q3 FY26 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary verified against official BSE/NSE filings.